UC San Diego SearchMenu
  • In Memoriam: William Loomis, Distinguished Professor of Biology, 1940-2016
  • Daniela Zarate Awarded 2016 NSF Graduate Research Fellowship
  • Leilani Cruz Named to Bouchet Graduate Honor Society


Synthetic Biology Used to Limit Bacterial Growth and Coordinate Drug Release

Researchers at the University of California San Diego and the Massachusetts Institute of Technology (MIT) have come up with a strategy for using synthetic biology in therapeutics. The approach enables continual production and release of drugs at disease sites in mice while simultaneously limiting the size, over time, of the populations of bacteria engineered to produce the drugs. The findings are published in the July 20 online issue of Nature.

UC San Diego researchers led by Jeff Hasty, a professor of bioengineering and biology, engineered a clinically relevant bacterium to produce cancer drugs and then self-destruct and release the drugs at the site of tumors.